Is Mirikizumab-mrkz Injection (Omvoh) in shortage?
Mirikizumab-mrkz Injection is listed by FDA as being discontinued by at least one maker (updated Dec 22, 2025).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Omvoh, Injection, 100 mg/1 mL (NDC 0002-8011-27)
A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-3116-11) will remain.
Maker contact: 800-545-5979
- Omvoh, Injection, 100 mg/1 mL (NDC 0002-8870-27)
A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-1442-11) will remain.
Maker contact: 800-545-5979
Mirikizumab-mrkz Injection shortage questions
Is Mirikizumab-mrkz Injection (Omvoh) in shortage?
Mirikizumab-mrkz Injection is listed by FDA as being discontinued by at least one maker (updated Dec 22, 2025).
What should I do if I can’t get Mirikizumab-mrkz Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.